Clinical Trial Update: The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of Gliatiline in post-stroke patients with vascular cognitive impairment no dementia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Vascular Cognitive Impairment
• Vascular Cognitive Impairment No Dementia

Drugs mentioned

• Gliatiline (Gliatiline)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Cognitive Impairment, Stroke | Phase 4 | Status: COMPLETED